Media
Media
Our latest announcements
Notice to Extraordinary General Meeting in Hansa Biopharma AB (publ)
Regulatory press release
21/08/2026
Hansa Biopharma Announces Confidential Submission of Draft Registration Statement to the SEC to allow for a potential Listing of ADSs in the United States
Regulatory press release
21/08/2026
Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia
18/08/2026
Hansa Biopharma Reports Second Quarter and First Half Year 2026 Financial Results
Regulatory press release
22/07/2026
Media articles
Insights
The Power of Hope: Redefining Treatment Decisions for Highly Sensitized Kidney Patients
07/08/2025
Collaboration across the continuum of care to improve equity for highly sensitized people in kidney transplantation
17/07/2024
A concerted collaboration to advance treatment options for people living with rare diseases
26/06/2024
Fueling the future: the role of biotech in advancing innovative science and delivering new medicines
02/05/2024
Patients' perspective
Life on tour with chronic kidney disease
“I had always played the guitar and wrote songs but never really did anything with it. Nothing was going to hold me back now! No more excuses… there wasn’t time!”
Patients' perspective
Suspended time: a journey from diagnosis to transplant
"Dialysis may sound simple, but it isn’t, and over the course of his treatment Ron underwent several different kinds, all of which made him feel awful."
